Tower Research Capital LLC (Trc) Cabaletta Bio, Inc. Transaction History

Tower Research Capital LLC (Trc)

$4.87 Billion
Q4 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 12,602 shares of CABA stock, worth $25,960. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,602

Previous 11,098 13.55%

Holding current value

$25,960

Previous $52,000 48.08%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$1.87 - $4.91 $2,812 - $7,384	1,504 Added 13.55%	12,602 $27,000
Q3 2024 Nov 14, 2024	SELL	$3.94 - $8.24 $1,989 - $4,161	-505 Reduced 4.35%	11,098 $52,000
Q2 2024 Aug 13, 2024	BUY	$7.22 - $18.82 $80,503 - $209,843	11,150 Added 2461.37%	11,603 $86,000
Q1 2024 May 15, 2024	SELL	$16.79 - $25.38 $36,434 - $55,074	-2,170 Reduced 82.73%	453 $7,000
Q4 2023 Feb 13, 2024	BUY	$12.21 - $23.36 $12,722 - $24,341	1,042 Added 65.91%	2,623 $59,000
Q3 2023 Nov 14, 2023	BUY	$11.84 - $18.65 $9,045 - $14,248	764 Added 93.51%	1,581 $24,000
Q2 2023 Aug 14, 2023	SELL	$7.65 - $13.95 $32,168 - $58,659	-4,205 Reduced 83.73%	817 $10,000
Q1 2023 May 09, 2023	BUY	$7.08 - $12.62 $792 - $1,413	112 Added 2.28%	5,022 $42,000
Q4 2022 Feb 10, 2023	SELL	$0.64 - $9.3 $8,081 - $117,440	-12,628 Reduced 72.0%	4,910 $45,000
Q3 2022 Nov 10, 2022	BUY	$0.63 - $2.05 $5,029 - $16,367	7,984 Added 83.57%	17,538 $11,000
Q2 2022 Aug 15, 2022	SELL	$0.99 - $2.11 $8,797 - $18,749	-8,886 Reduced 48.19%	9,554 $10,000
Q1 2022 May 12, 2022	BUY	$1.68 - $3.92 $27,960 - $65,240	16,643 Added 926.15%	18,440 $37,000
Q4 2021 Feb 14, 2022	BUY	$3.36 - $14.64 $1,192 - $5,197	355 Added 24.62%	1,797 $7,000
Q3 2021 Nov 15, 2021	SELL	$7.0 - $12.5 $13,601 - $24,287	-1,943 Reduced 57.4%	1,442 $18,000
Q2 2021 Aug 16, 2021	BUY	$7.2 - $11.73 $12,974 - $21,137	1,802 Added 113.83%	3,385 $30,000
Q1 2021 May 17, 2021	SELL	$10.39 - $14.53 $19,450 - $27,200	-1,872 Reduced 54.18%	1,583 $18,000
Q4 2020 Feb 16, 2021	SELL	$9.81 - $15.8 $90,036 - $145,012	-9,178 Reduced 72.65%	3,455 $43,000
Q3 2020 Nov 16, 2020	BUY	$9.71 - $14.41 $76,815 - $113,997	7,911 Added 167.53%	12,633 $137,000
Q2 2020 Aug 13, 2020	BUY	$6.39 - $11.28 $11,214 - $19,796	1,755 Added 59.15%	4,722 $52,000
Q1 2020 May 15, 2020	BUY	$6.0 - $18.67 $2,574 - $8,009	429 Added 16.9%	2,967 $22,000
Q4 2019 Feb 07, 2020	BUY	$7.88 - $17.71 $19,999 - $44,947	2,538 New	2,538 $35,000

Others Institutions Holding CABA

# of Institutions

115

Shares Held

39.6M

Call Options Held

297K

Put Options Held

98.6K

View Full List

About Cabaletta Bio, Inc.

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $59.8M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

More about CABA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Cabaletta Bio, Inc. Transaction History